Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46,239,275
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
13,991,634
-
Shares change
-
-337,753
-
Total reported value, excl. options
-
$249,248,555
-
Value change
-
-$10,038,151
-
Put/Call ratio
-
70%
-
Number of buys
-
32
-
Number of sells
-
42
-
Price
-
$17.84
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q1 2020
As of 31 Mar 2020 UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) had 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,991,634 shares of stock of the company.
Largest 10 holders included MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Wildcat Capital Management, LLC, Phoenix Holdings Ltd., Migdal Insurance & Financial Holdings Ltd., BAKER BROS. ADVISORS LP, CREDIT SUISSE AG/, Clal Insurance Enterprises Holdings Ltd, and STATE STREET CORP.
This table shows 78 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.